I am not clear on current time line that Cortex Pharm is moving forward with. Does anyone have any idea what the time table for the Phase II CX717 may look like. <A HREF="http://www.cortexpharm.com/pdfs/Roth_Presentation_2-21-07.pdf" target="_blank">http://www.cortexpharm.com/pdfs/Roth_Presentation_2-21-07.pdf</A>